Avita Medical | 1811094D - Operating Expenses


Avita Medical reported AUD28.56M in Operating Expenses for its fiscal semester ending in June of 2026.





Operating Expenses Change Date
Accuray USD 37.18M 567K Dec/2024
Celltrion KRW 133.99B 14.77B Jun/2026
Clinuvel Pharmaceuticals AUD 23.42M 6.49M Dec/2025
Cochlear AUD 914.9M 454.8M Dec/2025
CSL USD 5.7B 2.82B Dec/2025
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
Deva Holding AS TRY 1.35B 178.26M Sep/2023
Dianthus Therapeutics USD 62.24M 15.25M Jun/2026
Divis Laboratories Ltd INR 22.52B 3.01B Sep/2026
Kangmei Pharma CNY 1.22B 130.32M Jun/2026
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Laboratorios Farma EUR 313.62M 17.98M Dec/2023
Malin Corporation EUR 1.1M 400K Dec/2024
Mayne Pharma AUD 103.54M 9.39M Jun/2024
Medical Developments International AUD 21.61M 11.59M Dec/2025
Nanosonics AUD 93.11M 45.89M Dec/2025
Neuren Pharmaceuticals AUD 25.23M 16.54M Dec/2025
Organigram Holdings CAD 100.45M 30.86M Jun/2026
Ovoca Bio EUR 173K 990K Dec/2025
Pacific Edge NZD 22.5M 2.84M Jun/2026
Pharma Mar EUR 46.77M 4.24M Sep/2026
Polynovo AUD 68.22M 1.24M Dec/2025
PYC Therapeutics AUD 33.63M 14.33M Dec/2025
Qiagen NV USD 393.64M 17.95M Jun/2026
Ramsay Health Care AUD 8.8B 83.5M Dec/2025
ResMed USD 1.01B 83.34M Jun/2026
Sartorius EUR 746.5M 1.3M Sep/2026
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Telix Pharmaceuticals AUD 430.99M 25.59M Jun/2026
Tilray USD 237.52M 17.34M Sep/2025
Zealand Pharma A/S 573M 202.97M Mar/2026
Zz Pientze Pharmaceu CNY 1.54B 90.74M Sep/2026